KRAS and endometriosis: In addition, they found that VAFs for mutations encoding oncogenic KRAS p. G12/G13 alterations were significantly increased in the normal endometrium of adenomyosis patients compared with cases with neither adenomyosis nor endometriosis, which suggests that KRAS mutant clones were expanding in the normal endometrium of these adenomyosis patients.